Chemodex

Luteolin

CHF 41.00
In stock
CDX-L0087-M01010 mgCHF 41.00
CDX-L0087-M05050 mgCHF 102.00
More Information
Product Details
Synonyms 3',4',5,7-Tetrahydroxyflavone; Luteolol; BRN 0292084; C.I. Natural Yellow 2; Digitoflavone; Flacitran; Flavopurpol; Daphneflavonol; Argemexitin
Product Type Chemical
Properties
Formula C15H10O6
MW 286.24
CAS 491-70-3
RTECS LK9275210
Purity Chemicals ≥98% (TLC)
Appearance Yellow powder.
Solubility Soluble in DMSO (10mg/ml), DMF (20mg/ml), methanol or ethanol (5mg/ml). Slightly soluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key IQPNAANSBPBGFQ-UHFFFAOYSA-N
Smiles OC1=C2C(OC(C3=CC(O)=C(O)C=C3)=CC2=O)=CC(O)=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Luteolin is a hydroxylated flavone derivative that is a strong antioxidant and radical scavenger. It has multiple activities, such as anticancer, antimetastatic, anti-adipogenic, anti-inflammatory and neuroprotective. Luteolin has been described as a fatty acid synthase (FASN), 15-lipoxygenase, α-glucosidase, PPAR-γ, topoisomerase I, PI3K/Akt, RSK1/RSK2 and HDAC inhibitor.

Product References

(1) Y.T. Huang, et al.; Br. J. Pharmacol. 128, 999 (1999) | (2) J.S. Kim, et al.; Biosci. Biotechnol. Biochem. 64, 2458 (2000) | (3) H. Ueda, et al.; Biol. Pharm. Bull. 25, 1197 (2002) | (4) A.R. Chowdhury, et al.; Biochem. J. 366, 653 (2002) | (5) L. Sartor, et al.; Biochem. Pharmacol. 64, 229 (2002) | (6) C.D. Sadik, et al.; Biochem. Pharmacol. 65, 773 (2003) | (7) D.T. Coleman, et al.; Mol. Cancer Ther. 8, 214 (2009) | (8) K. Xu, et al.; Molecules 14, 3486 (2009) | (9) H.S. Park, et al.; Biofactors 35, 373 (2009) | (10) S. Attoub, et al.; Eur. J. Pharmacol. 651, 18 (2011) | (11) H.Y. Kim, et al.; Phytother. Res. 27, 1481 (2013) | (12) K.M. Reipas, et al.; Oncotarget 4, 329 (2013)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.